[(3aS,5aR,5bR,7aR,9S,11aR,11bR,13aR,13bR)-3a-[(2S)-2-[1-[2-(dimethylamino)ethyl]-4-pyridin-3-ylimidazol-2-yl]pyrrolidine-1-carbonyl]-5a,5b,8,8,11a-pentamethyl-1-(1-methylcyclopropyl)-1,2,3,4,5,6,7,7a,9,10,11,11b,12,13,13a,13b-hexadecahydrocyclopenta[a]chrysen-9-yl] acetate

C49H73N5O3 — CID 129124709

IUPAC[(3aS,5aR,5bR,7aR,9S,11aR,11bR,13aR,13bR)-3a-[(2S)-2-[1-[2-(dimethylamino)ethyl]-4-pyridin-3-ylimidazol-2-yl]pyrrolidine-1-carbonyl]-5a,5b,8,8,11a-pentamethyl-1-(1-methylcyclopropyl)-1,2,3,4,5,6,7,7a,9,10,11,11b,12,13,13a,13b-hexadecahydrocyclopenta[a]chrysen-9-yl] acetate
SMILESCC(=O)O[C@H]1CC[C@]2(C)[C@H]3CC[C@@H]4[C@H]5C(C6(C)CC6)CC[C@]5(C(=O)N5CCC[C@H]5c5nc(-c6cccnc6)cn5CCN(C)C)CC[C@@]4(C)[C@]3(C)CC[C@H]2C1(C)C
InChIInChI=1S/C49H73N5O3/c1-32(55)57-40-18-19-46(5)38(44(40,2)3)17-20-48(7)39(46)15-14-35-41-34(45(4)22-23-45)16-21-49(41,25-24-47(35,48)6)43(56)54-27-11-13-37(54)42-51-36(33-12-10-26-50-30-33)31-53(42)29-28-52(8)9/h10,12,26,30-31,34-35,37-41H,11,13-25,27-29H2,1-9H3/t34?,35-,37+,38+,39-,40+,41-,46+,47-,48-,49+/m1/s1
InChIKeyGBSQXLMIWYEVPL-VCDKLGFMSA-N
MW780.16 g/mol
LogP9.98
Rot. Bonds8

About [(3aS,5aR,5bR,7aR,9S,11aR,11bR,13aR,13bR)-3a-[(2S)-2-[1-[2-(dimethylamino)ethyl]-4-pyridin-3-ylimidazol-2-yl]pyrrolidine-1-carbonyl]-5a,5b,8,8,11a-pentamethyl-1-(1-methylcyclopropyl)-1,2,3,4,5,6,7,7a,9,10,11,11b,12,13,13a,13b-hexadecahydrocyclopenta[a]chrysen-9-yl] acetate

[(3aS,5aR,5bR,7aR,9S,11aR,11bR,13aR,13bR)-3a-[(2S)-2-[1-[2-(dimethylamino)ethyl]-4-pyridin-3-ylimidazol-2-yl]pyrrolidine-1-carbonyl]-5a,5b,8,8,11a-pentamethyl-1-(1-methylcyclopropyl)-1,2,3,4,5,6,7,7a,9,10,11,11b,12,13,13a,13b-hexadecahydrocyclopenta[a]chrysen-9-yl] acetate (PubChem CID 129124709) has the molecular formula C49H73N5O3 and a molecular weight of 780.16 g/mol. Its IUPAC name is [(3aS,5aR,5bR,7aR,9S,11aR,11bR,13aR,13bR)-3a-[(2S)-2-[1-[2-(dimethylamino)ethyl]-4-pyridin-3-ylimidazol-2-yl]pyrrolidine-1-carbonyl]-5a,5b,8,8,11a-pentamethyl-1-(1-methylcyclopropyl)-1,2,3,4,5,6,7,7a,9,10,11,11b,12,13,13a,13b-hexadecahydrocyclopenta[a]chrysen-9-yl] acetate.

Molecular Properties

Compound Name[(3aS,5aR,5bR,7aR,9S,11aR,11bR,13aR,13bR)-3a-[(2S)-2-[1-[2-(dimethylamino)ethyl]-4-pyridin-3-ylimidazol-2-yl]pyrrolidine-1-carbonyl]-5a,5b,8,8,11a-pentamethyl-1-(1-methylcyclopropyl)-1,2,3,4,5,6,7,7a,9,10,11,11b,12,13,13a,13b-hexadecahydrocyclopenta[a]chrysen-9-yl] acetate
PubChem CID129124709
Molecular FormulaC49H73N5O3
Molecular Weight780.16 g/mol
Exact Mass779.57
IUPAC Name[(3aS,5aR,5bR,7aR,9S,11aR,11bR,13aR,13bR)-3a-[(2S)-2-[1-[2-(dimethylamino)ethyl]-4-pyridin-3-ylimidazol-2-yl]pyrrolidine-1-carbonyl]-5a,5b,8,8,11a-pentamethyl-1-(1-methylcyclopropyl)-1,2,3,4,5,6,7,7a,9,10,11,11b,12,13,13a,13b-hexadecahydrocyclopenta[a]chrysen-9-yl] acetate
SMILESCC(=O)O[C@H]1CC[C@]2(C)[C@H]3CC[C@@H]4[C@H]5C(C6(C)CC6)CC[C@]5(C(=O)N5CCC[C@H]5c5nc(-c6cccnc6)cn5CCN(C)C)CC[C@@]4(C)[C@]3(C)CC[C@H]2C1(C)C
InChIInChI=1S/C49H73N5O3/c1-32(55)57-40-18-19-46(5)38(44(40,2)3)17-20-48(7)39(46)15-14-35-41-34(45(4)22-23-45)16-21-49(41,25-24-47(35,48)6)43(56)54-27-11-13-37(54)42-51-36(33-12-10-26-50-30-33)31-53(42)29-28-52(8)9/h10,12,26,30-31,34-35,37-41H,11,13-25,27-29H2,1-9H3/t34?,35-,37+,38+,39-,40+,41-,46+,47-,48-,49+/m1/s1
InChIKeyGBSQXLMIWYEVPL-VCDKLGFMSA-N
XLogP9.98
TPSA80.56 Ų
H-Bond Donors
H-Bond Acceptors7
Rotatable Bonds8
Heavy Atoms57
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500780.16
LogP ≤ 59.98
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 107

Analyze [(3aS,5aR,5bR,7aR,9S,11aR,11bR,13aR,13bR)-3a-[(2S)-2-[1-[2-(dimethylamino)ethyl]-4-pyridin-3-ylimidazol-2-yl]pyrrolidine-1-carbonyl]-5a,5b,8,8,11a-pentamethyl-1-(1-methylcyclopropyl)-1,2,3,4,5,6,7,7a,9,10,11,11b,12,13,13a,13b-hexadecahydrocyclopenta[a]chrysen-9-yl] acetate with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of [(3aS,5aR,5bR,7aR,9S,11aR,11bR,13aR,13bR)-3a-[(2S)-2-[1-[2-(dimethylamino)ethyl]-4-pyridin-3-ylimidazol-2-yl]pyrrolidine-1-carbonyl]-5a,5b,8,8,11a-pentamethyl-1-(1-methylcyclopropyl)-1,2,3,4,5,6,7,7a,9,10,11,11b,12,13,13a,13b-hexadecahydrocyclopenta[a]chrysen-9-yl] acetate?
The IUPAC name of [(3aS,5aR,5bR,7aR,9S,11aR,11bR,13aR,13bR)-3a-[(2S)-2-[1-[2-(dimethylamino)ethyl]-4-pyridin-3-ylimidazol-2-yl]pyrrolidine-1-carbonyl]-5a,5b,8,8,11a-pentamethyl-1-(1-methylcyclopropyl)-1,2,3,4,5,6,7,7a,9,10,11,11b,12,13,13a,13b-hexadecahydrocyclopenta[a]chrysen-9-yl] acetate (CID 129124709) is [(3aS,5aR,5bR,7aR,9S,11aR,11bR,13aR,13bR)-3a-[(2S)-2-[1-[2-(dimethylamino)ethyl]-4-pyridin-3-ylimidazol-2-yl]pyrrolidine-1-carbonyl]-5a,5b,8,8,11a-pentamethyl-1-(1-methylcyclopropyl)-1,2,3,4,5,6,7,7a,9,10,11,11b,12,13,13a,13b-hexadecahydrocyclopenta[a]chrysen-9-yl] acetate.
What is the SMILES notation for [(3aS,5aR,5bR,7aR,9S,11aR,11bR,13aR,13bR)-3a-[(2S)-2-[1-[2-(dimethylamino)ethyl]-4-pyridin-3-ylimidazol-2-yl]pyrrolidine-1-carbonyl]-5a,5b,8,8,11a-pentamethyl-1-(1-methylcyclopropyl)-1,2,3,4,5,6,7,7a,9,10,11,11b,12,13,13a,13b-hexadecahydrocyclopenta[a]chrysen-9-yl] acetate?
The canonical SMILES for [(3aS,5aR,5bR,7aR,9S,11aR,11bR,13aR,13bR)-3a-[(2S)-2-[1-[2-(dimethylamino)ethyl]-4-pyridin-3-ylimidazol-2-yl]pyrrolidine-1-carbonyl]-5a,5b,8,8,11a-pentamethyl-1-(1-methylcyclopropyl)-1,2,3,4,5,6,7,7a,9,10,11,11b,12,13,13a,13b-hexadecahydrocyclopenta[a]chrysen-9-yl] acetate is CC(=O)O[C@H]1CC[C@]2(C)[C@H]3CC[C@@H]4[C@H]5C(C6(C)CC6)CC[C@]5(C(=O)N5CCC[C@H]5c5nc(-c6cccnc6)cn5CCN(C)C)CC[C@@]4(C)[C@]3(C)CC[C@H]2C1(C)C.
What is the InChIKey of [(3aS,5aR,5bR,7aR,9S,11aR,11bR,13aR,13bR)-3a-[(2S)-2-[1-[2-(dimethylamino)ethyl]-4-pyridin-3-ylimidazol-2-yl]pyrrolidine-1-carbonyl]-5a,5b,8,8,11a-pentamethyl-1-(1-methylcyclopropyl)-1,2,3,4,5,6,7,7a,9,10,11,11b,12,13,13a,13b-hexadecahydrocyclopenta[a]chrysen-9-yl] acetate?
The InChIKey is GBSQXLMIWYEVPL-VCDKLGFMSA-N. The full InChI is InChI=1S/C49H73N5O3/c1-32(55)57-40-18-19-46(5)38(44(40,2)3)17-20-48(7)39(46)15-14-35-41-34(45(4)22-23-45)16-21-49(41,25-24-47(35,48)6)43(56)54-27-11-13-37(54)42-51-36(33-12-10-26-50-30-33)31-53(42)29-28-52(8)9/h10,12,26,30-31,34-35,37-41H,11,13-25,27-29H2,1-9H3/t34?,35-,37+,38+,39-,40+,41-,46+,47-,48-,49+/m1/s1.
What are the key properties of [(3aS,5aR,5bR,7aR,9S,11aR,11bR,13aR,13bR)-3a-[(2S)-2-[1-[2-(dimethylamino)ethyl]-4-pyridin-3-ylimidazol-2-yl]pyrrolidine-1-carbonyl]-5a,5b,8,8,11a-pentamethyl-1-(1-methylcyclopropyl)-1,2,3,4,5,6,7,7a,9,10,11,11b,12,13,13a,13b-hexadecahydrocyclopenta[a]chrysen-9-yl] acetate?
[(3aS,5aR,5bR,7aR,9S,11aR,11bR,13aR,13bR)-3a-[(2S)-2-[1-[2-(dimethylamino)ethyl]-4-pyridin-3-ylimidazol-2-yl]pyrrolidine-1-carbonyl]-5a,5b,8,8,11a-pentamethyl-1-(1-methylcyclopropyl)-1,2,3,4,5,6,7,7a,9,10,11,11b,12,13,13a,13b-hexadecahydrocyclopenta[a]chrysen-9-yl] acetate has a molecular weight of 780.16 g/mol, XLogP of 9.98, 8 rotatable bonds, 0 hydrogen bond donors, and 7 hydrogen bond acceptors.
Where does this data come from?
All data for [(3aS,5aR,5bR,7aR,9S,11aR,11bR,13aR,13bR)-3a-[(2S)-2-[1-[2-(dimethylamino)ethyl]-4-pyridin-3-ylimidazol-2-yl]pyrrolidine-1-carbonyl]-5a,5b,8,8,11a-pentamethyl-1-(1-methylcyclopropyl)-1,2,3,4,5,6,7,7a,9,10,11,11b,12,13,13a,13b-hexadecahydrocyclopenta[a]chrysen-9-yl] acetate is sourced from PubChem (CID 129124709), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).